- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
History-based breast MR generates high yields
Screening women with breast MRI based solely on a personal history of breast cancer found malignancies in 12% of the women studied, with a positive predictive value biopsy rate of 39%.
Screening women with breast MRI based solely on a personal history of breast cancer found malignancies in 12% of the women studied, with a positive predictive value biopsy rate of 39%.
A retrospective review of 1699 breast MRI exams performed from 1999 to 2001 yielded 144 women with prior breast cancer who started regular breast MRI screening. Of the 144 women, 31% underwent biopsies prompted by MRI (AJR 2010;195:510-516).
Sixty-one biopsies found 17 carcinomas and one myxoid liposarcoma. The 10 detected by MRI were more likely than the other seven to be ductal carcinoma in situ or node-negative invasive breast cancer <1 cm in size.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.
